Cite
HARVARD Citation
Moazedi-Fuerst, F. et al. (2014). Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases Results of a lower dosage and shorter interval regimen. Scandinavian journal of rheumatology. pp. 257-258. [Online].